N-(2-(4-(2-((5-chloropyridin-2-yl)amino)acetamido)piperidin-1-yl)ethyl)-5-guanidinopentanamide tris(2,2,2-trifluoroacetate)

ID: ALA5184106

Chembl Id: CHEMBL5184106

PubChem CID: 168280936

Max Phase: Preclinical

Molecular Formula: C26H36ClF9N8O8

Molecular Weight: 452.99

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCCCCC(=O)NCCN1CCC(NC(=O)CNc2ccc(Cl)cn2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C20H33ClN8O2.3C2HF3O2/c21-15-4-5-17(26-13-15)27-14-19(31)28-16-6-10-29(11-7-16)12-9-24-18(30)3-1-2-8-25-20(22)23;3*3-2(4,5)1(6)7/h4-5,13,16H,1-3,6-12,14H2,(H,24,30)(H,26,27)(H,28,31)(H4,22,23,25);3*(H,6,7)

Standard InChI Key:  XZWCXVUJDLZCGH-UHFFFAOYSA-N

Associated Targets(Human)

TZM (838 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

env Envelope glycoprotein gp160 (755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 452.99Molecular Weight (Monoisotopic): 452.2415AlogP: 0.50#Rotatable Bonds: 12
Polar Surface Area: 148.26Molecular Species: BASEHBA: 6HBD: 6
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 7#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 12.20CX LogP: -0.92CX LogD: -3.81
Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.15Np Likeness Score: -1.56

References

1. Tsuji K, Kobayakawa T, Konno K, Masuda A, Takahashi K, Ohashi N, Yoshimura K, Kuwata T, Matsushita S, Harada S, Tamamura H..  (2022)  Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitors.,  56  [PMID:35063895] [10.1016/j.bmc.2022.116616]

Source